Role of endothelin-1 in atherosclerosis

Annals of the New York Academy of Sciences

Volumn 902, Issue , 2000, Pages 84-94

  Fan, Jianglin ^a   Unoki, Hiroyuki ^a   Iwasa, Satoshi ^a   Watanabe, Teruo ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; ENDOTHELIN 1; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; RECEPTOR SUBTYPE;

ARTERY WALL; ATHEROSCLEROSIS; CELL CULTURE; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; FOAM CELL; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNOREACTIVITY; KNOCKOUT MOUSE; MACROPHAGE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALIA;

EID: 0034049990     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06303.x     Document Type: Conference Paper

References (27)

1. 1. YANAGISAWA, M., H. KURIHARA, S. KIMURA, Y. TOMOBE, M. KOBAYASHI, Y. MITSUI, Y. YAZAKI, K. GOTO & T. MASAKI. 1988. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415.
2. 2. RUBANYI, G.M. & M.A. POLOKOFF. 1994. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol. Rev. 46: 325-415.
3. 3. TAMIRISA, P., W.H. FRISHMAN & A. KUMAR. 1995. Endothelin and endothelin antagonism: roles in cardiovascular health and disease. Am. Heart J. 130: 601-610.
4. 4. GOTO, K., H. HAMA & Y. KASUYA. 1996. Molecular pharmacology and pathophysiological significance of endothelin. Jpn. J. Pharmacol. 72: 261-290.
5. 5. LERMAN, A., B.S. EDWARDS, J.W. HALLETT, D.M. HEUBLEIN, S.M. SANDBERG & J.C. BURNETT, JR. 1991. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N. Engl. J. Med. 325: 997-1001.
6. 6. TOKUNAGA, O., J. FAN, T. WATANABE, M. KOBAYASHI, T. KUMAZAKI & Y. MITSUI. 1992. Endothelin. Immunohistologic localization in aorta and biosynthesis by cultured human aortic endothelial cells. Lab. Invest. 67: 210-217.
7. 7. LERMAN, A., M.W.I. WEBSTER, J.H. CHESEBRO, W.D. EDWARDS, C.M. WEI, V. FusTER & J.C. BURNETT, JR. 1993. Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs. Circulation 88: 2923-2928.
8. 8. WINKLES, J.A., G.F. ALBERTS, E. BROGI & P. LIBBY. 1993. Endothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries. Biochem. Biophys. Res. Commun. 191: 1081-1088.
9. 9. ZEIHER, A.M., C. IHLING, K. PISTORIUS, V. SCHACHINGER & H.E. SCHAEFER. 1994. Increased tissue endothelin immunoreactivity in atherosclerotic lesions associated with acute coronary syndromes. Lancet 344: 1405-1406.
10. 10. MCCARRON, R.M., L. WANG, D.B. STANIMIROVIC & M. SPATZ. 1993. Endothelin induction of adhesion molecule expression on human brain microvascular endothelial cells. Neurosci. Lett. 156: 31-34.
11. 11. ACHMAD, T.H. & G.S. RAO. 1992. Chemotaxis of human blood monocytes toward endothelin-1 and the influence of calcium channel blockers. Biochem. Biophys. Res. Commun. 189: 994-1000.
12. 12. HELSET, E., T. SILDNES & Z.S. KONOPSKI. 1994. Endothelin-1 stimulates monocytes in vitro to release chemotactic activity identified as interleukin-8 and monocyte chemotactic protein-1. Mediators Inflammation 3: 155-160.
13. 13. JANAKIDEVI, K., M.A. FISHER, P.J. DEL VECCHIO, C. TIRUPPATHI, J. FIGGE & A.B. MALIK. 1992. Endothelin-1 stimulates DNA synthesis and proliferation of pulmonary artery smooth muscle cells. Am. J. Physiol. 263(Cell. Physiol. 32): C1295-C1301.
14. 14. KOWALA, M.C., P.M. ROSE, P.D. STEIN, N. GOLLER, R. RECCE, S. BEYER, M. VALENTINE, D. BARTON & S.K. DURHAM. 1995. Selective blockade of the endothelin subtype A receptor decreases early atherosclerosis in hamsters fed cholesterol. Am. J. Pathol. 146: 819-826.
15. 15. BARTON, M., C.C. HAUDENSCHILD, L.V. DUSCIO, S. SHAW, K. MUNTER & T.F. LUSCHER. 1998. Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. Proc. Natl. Acad. Sci. USA 95: 14367-14372.
16. 16. IWASA, S., J. FAN, T. SHIMOKAMA, M. NAGATA & T. WATANABE. 1999. Increased immunoactivity of endothelin-1 and endothelin B receptor in human atherosclerotic lesions. A possible role in atherogenesis. Atherosclerosis 146: 93-100.
17. 17. KOBAYASHI, T. et al. 2000. Pathol. Int. (In press.)
18. 18. UYAMA, H., S. HARAOKA, T. SHIMOKAMA, K. GOTO, K. DOHI & T. WATANABE. 1996. Diet-induced hypercholesterolemia increases endothelin-1 release by aortic endothelial cells. Pathobiology 64: 238-332.
19. 19. HAAK, H.T., W. MARZ, E. JUNGMANN, S. HAUSSER, R. SIEKMEIER, W. GROSS & K.H. USADEL. 1994. Elevated endothelin levels in patients with hypercholesterolemia. Clin. Invest. 72: 580-584.
20. 20. MIYAUCHI, T., Y. SUGISHIMA, M. MATSUDA, H. SAKAI, N. SUZUKI, T. MASAKI & K. GOTO. 1992. Increased plasma concentration of endothelin-1 in cholesterol-fed rats. Atherosclerosis 93: 257-259.
21. 21. STEINBERG, D., S. PARTHASARATHY, T.E. CAREW, J.C. KHOO & J.L. WITZTUM. 1989. Beyond cholesterol. Modifications of low-density lipoproteins that increase its atherogenicity. N. Engl. J. Med. 320: 915-924.
22. 22. WITZTUM, J.L. & D. STEINBERG. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88: 1785-1792.
23. 23. YAMADA, T., J. FAN, T. SHIMOKAMA, O. TOKUNAGA & T. WATANABE. 1992. Induction of fatty streak-like lesions in vitro using a culture model system simulating arterial intima. Am. J. Pathol. 141: 1435-1444.
24. 24. UNOKI, H., J. FAN & T. WATANABE. 1999. Low density lipoproteins modulate endothelial cells to secrete endothelin-1 in a polarized pattern: a study using a culture model system simulating arterial intima. Cell Tissue Res. 295: 89-99.
25. 25. KISHIKAWA, H., T. SHIMOKAMA & T. WATANABE. 1993. Localization of T lymphocytes and macrophages expressing IL-1, IL-2 receptor, IL-6 and TNF in human aortic intima. Role of cell-mediated immunity in human atherogenesis. Virch. Arch. A Pathol. Anat. Histol. Pathol. 423: 433-442.
26. 26. KASHYAP, M.L. 1989. Basic considerations in the reversal of atherosclerosis: significance of high density lipoproteins in stimulating reverse cholesterol transport. Am. J. Cardiol. 63: 56H-59H.
27. 27. IWASA, S., J. FAN, T. MIYAUCHI & T. WATANABE. 1999. Circulation (Suppl I) 100: 1-474.